Meet the 10 Market Stars Behind Millionaire-Making in 2025

Page 9 of 9

1. ABIVAX Societe Anonyme (NASDAQ:ABVX)

Abivax skyrocketed by 1,742.28 percent in 2025, as investor sentiment was primarily bolstered by a series of upbeat analyst outlooks, strong clinical trial results, and its official inclusion in Nasdaq’s biotechnology index.

ABIVAX Societe Anonyme (NASDAQ:ABVX) officially joined the Nasdaq biotechnology index (NBI) on December 22, an index designed to track the performance of a set of biotechnology and pharmaceutical companies listed on Nasdaq.

Companies belonging to the index must meet eligibility requirements, including minimum market capitalization, average daily trading volume, and seasoning as a public company, among other criteria.

“Our inclusion in the Nasdaq Biotechnology Index marks a significant milestone for Abivax. It highlights the meaningful progress we’ve made as a company, particularly in advancing obefazimod through the successful Phase 3 ABTECT Induction trials for ulcerative colitis and reflects the increased visibility and perception of Abivax within the global biotechnology community,” said ABIVAX Societe Anonyme (NASDAQ:ABVX) Chief Finance Officer Didier Blondel.

Meanwhile, ABIVAX Societe Anonyme (NASDAQ:ABVX) also earned “buy” recommendations from a series of investment companies, namely Guggenheim Securities, Truist Financial, and Citizens, alongside price targets of $175, $140, and $131, respectively, reflecting upbeat analyst outlooks.

The coverage followed strong results from the phase 3 trial to test the efficacy of obefazimod in patients with moderate to severe ulcerative colitis, where enrolled patients who took 50 mg of obefazimod saw a significant improvement in their conditions and their colon lining, suggesting real disease healing.

While we acknowledge the potential of ABVX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ABVX and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.

Page 9 of 9